[{"address1": "2 Holzman Street", "address2": "Science Park PO Box 4081", "city": "Rehovot", "zip": "7670402", "country": "Israel", "phone": "972 8 940 6472", "fax": "972 8 940 6473", "website": "https://www.kamada.com", "industry": "Drug Manufacturers - Specialty & Generic", "industryKey": "drug-manufacturers-specialty-generic", "industryDisp": "Drug Manufacturers - Specialty & Generic", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Kamada Ltd. manufactures and sells plasma-derived protein therapeutics. Its commercial products include KAMRAB/KEDRAB for treating prophylaxis of rabies; CYTOGAM for Prophylaxis of Cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplants; VARIZIG for post exposure prophylaxis of varicella; WINRHO SDF for immune thrombocytopenic purpura and suppression of rhesus isoimmunization; HEPAGAM B for prevention of hepatitis B recurrence liver transplants and post-exposure prophylaxis; GLASSIA for intravenous AATD; KAMRHO (D) IM for prophylaxis of hemolytic disease of newborns; KAMRHO (D) IV for immune thermobocytopunic purpura; and Echis coloratus and Vipera palaestinae Antiserum for the treatment of snake bite. The company also distributes imported drug products in Israel, including BRAMITOB to manage chronic pulmonary infection; FOSTER to treat asthma; TRIMBOW for chronic obstructive pulmonary disease; PROVOCHOLINE for the diagnosis of bronchial airway hyperactivity; AEROBIKA, an OPEP device; RUPAFIN and RUPAFIN ORAL SOLUTION for allergic rhinitis and Urticaria; SINTREDIUS for rheumatoid arthritis, systemic lupus erythematosus, and mild-moderate juvenile dermatomyositis; IVIG for immunodeficiency-related conditions; VARITECT for chicken pox and zoster herpes; ZUTECTRA and HEPATECT CP for hepatitis B; MEGALOTECT CP for CMV virus; RUCONEST for angioedema attack; HEPARIN SODIUM INJECTION for thrombo-embolic disorders and prophylaxis of deep vein thrombosis and thromboembolic events; ALBUMIN and ALBUMIN for blood plasma; Factor VIII for hemophilia type A; and Factor IX for hemophilia type B. In addition, it distributes COAGADEX for hereditary factor X deficiency; IXIARO for Japanese encephalitis; VIVOTIF for Salmonella Typhi; PROCYSBI for nephropathic cystinosis; LAMZEDE for alpha-mannosidosis; ELIGARD for prostate cancer; and BEVACIZUMAB KAMADA for various cancers. The company was incorporated in 1990 and is headquartered in Rehovot, Israel.", "fullTimeEmployees": 420, "companyOfficers": [{"maxAge": 1, "name": "Mr. Amir  London", "age": 55, "title": "Chief Executive Officer", "yearBorn": 1969, "fiscalYear": 2024, "totalPay": 674000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Chaime  Orlev", "age": 54, "title": "Chief Financial Officer", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 478000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Eran  Nir", "age": 51, "title": "Chief Operating Officer", "yearBorn": 1973, "fiscalYear": 2024, "totalPay": 417000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jon R. Knight", "age": 58, "title": "Vice President of US Commercial Operations", "yearBorn": 1966, "fiscalYear": 2024, "totalPay": 302000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Boris  Gorelik", "age": 42, "title": "Vice President of Business Development & Strategic Programs", "yearBorn": 1982, "fiscalYear": 2024, "totalPay": 392000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. David  Tsur", "age": 74, "title": "Co-Founder & Independent Deputy Chairman of the Board", "yearBorn": 1950, "fiscalYear": 2024, "totalPay": 252000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Nir  Livneh B.A., L.L.B.", "age": 44, "title": "VP, General Counsel & Corporate Secretary", "yearBorn": 1980, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Hanni  Neheman", "age": 54, "title": "Vice President of Marketing & Sales", "yearBorn": 1970, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Liron  Reshef", "age": 52, "title": "Vice President of Human Resources", "yearBorn": 1972, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Shavit  Beladev", "title": "Vice President of Kamada Plasma", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 7.23, "open": 7.18, "dayLow": 7.0903, "dayHigh": 7.265, "regularMarketPreviousClose": 7.23, "regularMarketOpen": 7.18, "regularMarketDayLow": 7.0903, "regularMarketDayHigh": 7.265, "exDividendDate": 1742169600, "payoutRatio": 0.0, "beta": 0.211, "trailingPE": 28.72, "forwardPE": 23.16129, "volume": 72238, "regularMarketVolume": 72238, "averageVolume": 211151, "averageVolume10days": 161180, "averageDailyVolume10Day": 161180, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 416484512, "fiftyTwoWeekLow": 4.74, "fiftyTwoWeekHigh": 9.15, "priceToSalesTrailing12Months": 2.5876157, "fiftyDayAverage": 7.1648, "twoHundredDayAverage": 5.95905, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 345513120, "profitMargins": 0.08984999, "floatShares": 9184704, "sharesOutstanding": 57505000, "sharesShort": 35081, "sharesShortPriorMonth": 7899, "sharesShortPreviousMonthDate": 1738281600, "dateShortInterest": 1740700800, "sharesPercentSharesOut": 0.00059999997, "heldPercentInsiders": 0.07218, "heldPercentInstitutions": 0.50004, "shortRatio": 0.11, "shortPercentOfFloat": 0.0011, "impliedSharesOutstanding": 58006200, "bookValue": 4.512, "priceToBook": 1.5913119, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "earningsQuarterlyGrowth": -0.247, "netIncomeToCommon": 14462000, "trailingEps": 0.25, "forwardEps": 0.31, "enterpriseToRevenue": 2.147, "enterpriseToEbitda": 10.675, "52WeekChange": 0.22316861, "SandP52WeekChange": 0.09506309, "lastDividendValue": 0.006, "lastDividendDate": 1371081600, "quoteType": "EQUITY", "currentPrice": 7.18, "targetHighPrice": 20.0, "targetLowPrice": 11.0, "targetMeanPrice": 14.25, "targetMedianPrice": 13.0, "recommendationMean": 1.5, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 4, "totalCash": 78435000, "totalCashPerShare": 1.364, "ebitda": 32367000, "totalDebt": 11062000, "quickRatio": 2.058, "currentRatio": 3.733, "totalRevenue": 160952992, "debtToEquity": 4.263, "revenuePerShare": 2.8, "returnOnAssets": 0.03447, "returnOnEquity": 0.05745, "grossProfits": 69967000, "freeCashflow": 24431876, "operatingCashflow": 47594000, "earningsGrowth": -0.186, "revenueGrowth": 0.071, "grossMargins": 0.4347, "ebitdaMargins": 0.2011, "operatingMargins": 0.13019, "financialCurrency": "USD", "symbol": "KMDA", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketChangePercent": -0.6915656, "regularMarketPrice": 7.18, "corporateActions": [{"header": "Dividend", "message": "KMDA announced a cash dividend of 0.20 with an ex-date of Mar. 17, 2025", "meta": {"eventType": "DIVIDEND", "dateEpochMs": 1742184000000, "amount": "0.20"}}], "postMarketTime": 1741991207, "regularMarketTime": 1741982400, "exchange": "NMS", "messageBoardId": "finmb_9002466", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "marketState": "CLOSED", "shortName": "Kamada Ltd.", "longName": "Kamada Ltd.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1370007000000, "epsTrailingTwelveMonths": 0.25, "epsForward": 0.31, "epsCurrentYear": 0.29, "priceEpsCurrentYear": 24.758621, "fiftyDayAverageChange": 0.015199661, "fiftyDayAverageChangePercent": 0.0021214355, "twoHundredDayAverageChange": 1.2209496, "twoHundredDayAverageChangePercent": 0.20488998, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.5 - Strong Buy", "cryptoTradeable": false, "postMarketChangePercent": 1.81059, "postMarketPrice": 7.31, "postMarketChange": 0.13, "regularMarketChange": -0.05000019, "regularMarketDayRange": "7.0903 - 7.265", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 211151, "fiftyTwoWeekLowChange": 2.44, "fiftyTwoWeekLowChangePercent": 0.51476794, "fiftyTwoWeekRange": "4.74 - 9.15", "fiftyTwoWeekHighChange": -1.9699998, "fiftyTwoWeekHighChangePercent": -0.21530053, "fiftyTwoWeekChangePercent": 22.31686, "dividendDate": 1743984000, "earningsTimestamp": 1741176300, "earningsTimestampStart": 1746534600, "earningsTimestampEnd": 1747053000, "earningsCallTimestampStart": 1741179600, "earningsCallTimestampEnd": 1741179600, "isEarningsDateEstimate": true, "displayName": "Kamada", "trailingPegRatio": 1.0566, "__fetch_time": "2025-03-15"}]